Willow NAD+ Review: $199 Plan, Supply, and Support

Willow publishes a straightforward $199/month NAD+ injection headline and describes the home-injection routine before you begin. Its main weakness is that the public product page does not state the vial strength or total monthly milligrams. That makes the price easy to find but harder to compare with a plan that tells you exactly how much medication it supplies.

We checked Willow's public NAD+ page and terms. We did not complete the assessment, order medication, or test its support. This review evaluates the current published offer and its limitations; it is not a patient testimonial or an individual prescription quote.

A clear price and an injection-only offer

The NAD+ page advertises $199 per month, free shipping, online physician assessment, and HSA/FSA eligibility. It describes a subcutaneous injection and a supplied vial, syringes, and needles, with ongoing doctor access and patient-care support.¹

That is useful information for someone assessing the practical burden of treatment. If you are uncomfortable injecting at home, Willow's NAD+ offer is not the obvious starting point. CoreAge and RxSpan discuss non-injection alternatives, though a different route does not establish a proven benefit either.

HSA/FSA eligibility should also be confirmed with your plan administrator. A badge is not a guarantee of reimbursement for every purchaser, and it is not an insurance-coverage statement. Keep the prescription and receipt if your administrator asks for documentation.

The schedule is described; the supplied quantity is not

Willow describes an initial schedule of three injections weekly, followed after the first month by continued use at that frequency or a transition to weekly use with the doctor's guidance.¹ This is the company's general description, not a schedule for a reader to adopt without a prescription.

The unresolved question is how the schedule relates to the vial and price. We did not find the product page stating a concentration or total monthly milligrams. Without those details, we cannot calculate a meaningful cost per milligram or determine whether another provider's monthly plan supplies the same quantity.

Ask for the amount in each vial, concentration, prescribed amount, expected refill interval, and beyond-use date. If the clinician changes frequency, ask whether the refill quantity and bill change as well. A less frequent schedule does not automatically tell you how long an opened vial remains usable. The dispensing instructions need to answer that question for the actual preparation.

Pharmacy disclosure is useful, but not order-specific

Willow's current terms name these pharmacy partners: Red Rock Home Pharmacy, Epiq Pharmacy, Absolute Pharmacy, The Pharmacy Hub, and Empower Pharmacy. They also distinguish the platform from independent medical and pharmacy services.² Naming partners is helpful because it gives prospective patients a clearer picture of the fulfillment network.

The list does not establish which pharmacy will fill your NAD+ order. We would not assume an assignment from an old review or from a pharmacy name attached to a different treatment. Ask Willow or the prescriber to identify the actual dispensing pharmacy and provide a contact route for questions about storage, the label, or shipment condition.

A good medication handoff makes those details easy to find. It is especially useful when support is divided between a platform handling billing, a practice handling medical decisions, and a pharmacy handling preparation. Knowing which team answers which question can prevent a frustrating loop after delivery.

The headline is not a lifetime price promise

Willow's terms say subscription charges renew until cancellation under the applicable policy. They allow changes when the prescription or refill frequency changes, with disclosure and any required consent before a changed charge. They also describe returning payment when a consultation does not lead to a required prescription.²

That is why we describe $199 as the current advertised monthly price, rather than a guaranteed same-price-at-every-dose offer. Before enrolling, ask for the total at checkout, renewal interval, cancellation deadline, and the separate policy governing an order already underway. The terms point to more specific subscription and return policies; we did not test cancellation in a patient account.

Keep a copy of the selected terms. If you only want to stop the next renewal, say so clearly. If you want to cancel the current order too, ask whether pharmacy processing has already started. A canceled subscription is not automatically a refund of a filled prescription.

Testimonials do not settle the brain-fog question

Willow markets clearer thinking and steadier energy, and displays patient accounts of noticing changes.¹ Those accounts can explain why people are interested. They do not establish the average result or how much of a change was caused by NAD+ rather than other care or expectations.

In the randomized research cited here, oral NR did not improve cognition versus placebo.³⁴ Those precursor studies are not trials of Willow's injection. They cannot establish that Willow's product works, and they cannot supply a reliable timetable for a cognitive benefit.

A useful clinical discussion starts with a specific goal: what is difficult now, how often it happens, and what would count as a meaningful change. It should also establish when to reassess, when to stop, and what needs investigation if symptoms persist. That is more informative than choosing a treatment because a testimonial describes an immediate lift.

Compounded NAD+ is not FDA-approved, and compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality before marketing.⁵ Willow acknowledges the compounded-product limitation on its NAD+ page. Physician involvement does not remove that evidence gap.

Who we would consider it for

Willow may suit someone already discussing compounded NAD+ with a clinician who wants a described home-injection routine and a published monthly headline. The support access and named pharmacy network are useful features to ask about. We cannot judge their quality from a product page alone.

We would be less inclined to start here if you need a needle-free option, want to compare quantity precisely, or are expecting a proven remedy for concentration problems. Before paying, resolve the supply and refill questions and compare the written offer with the NAD+ injection board.

Our verdict: Willow makes the shopping page understandable, but the missing strength and supply details leave an important part of the comparison unfinished. The $199 headline is a useful starting point, not the whole offer. Read the NAD+ brain-fog evidence review alongside it, and use a clinician visit to assess the underlying complaint before committing to a recurring wellness purchase. HealthRX offers a useful supply-and-price comparison; AgelessRx is another longevity platform to assess on its own disclosures.